These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
398 related items for PubMed ID: 30825650
21. Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia. Seefried L, Kishnani PS, Moseley S, Denker AE, Watsky E, Whyte MP, Dahir KM. Bone; 2021 Jan; 142():115664. PubMed ID: 32987199 [Abstract] [Full Text] [Related]
22. Physiological role of alkaline phosphatase explored in hypophosphatasia. Whyte MP. Ann N Y Acad Sci; 2010 Mar; 1192():190-200. PubMed ID: 20392236 [Abstract] [Full Text] [Related]
23. Asfotase alfa: enzyme replacement for the treatment of bone disease in hypophosphatasia. Hofmann C, Seefried L, Jakob F. Drugs Today (Barc); 2016 May; 52(5):271-85. PubMed ID: 27376160 [Abstract] [Full Text] [Related]
24. Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients. Whyte MP, Zhang F, Wenkert D, McAlister WH, Mack KE, Benigno MC, Coburn SP, Wagy S, Griffin DM, Ericson KL, Mumm S. Bone; 2015 Jun; 75():229-39. PubMed ID: 25731960 [Abstract] [Full Text] [Related]
25. Efficacy and safety of asfotase alfa in patients with hypophosphatasia: A systematic review. Shirinezhad A, Esmaeili S, Azarboo A, Tavakoli Y, Hoveidaei AH, Zareshahi N, Ghaseminejad-Raeini A. Bone; 2024 Nov; 188():117219. PubMed ID: 39089608 [Abstract] [Full Text] [Related]
26. Hypophosphatasia: Canadian update on diagnosis and management. Khan AA, Josse R, Kannu P, Villeneuve J, Paul T, Van Uum S, Greenberg CR. Osteoporos Int; 2019 Sep; 30(9):1713-1722. PubMed ID: 30915507 [Abstract] [Full Text] [Related]
28. Investigation of ALPL variant states and clinical outcomes: An analysis of adults and adolescents with hypophosphatasia treated with asfotase alfa. Kishnani PS, Del Angel G, Zhou S, Rush ET. Mol Genet Metab; 2021 May; 133(1):113-121. PubMed ID: 33814268 [Abstract] [Full Text] [Related]
29. Safety and efficacy of treatment with asfotase alfa in patients with hypophosphatasia: Results from a Japanese clinical trial. Kitaoka T, Tajima T, Nagasaki K, Kikuchi T, Yamamoto K, Michigami T, Okada S, Fujiwara I, Kokaji M, Mochizuki H, Ogata T, Tatebayashi K, Watanabe A, Yatsuga S, Kubota T, Ozono K. Clin Endocrinol (Oxf); 2017 Jul; 87(1):10-19. PubMed ID: 28374482 [Abstract] [Full Text] [Related]